v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
May 02, 2026
May 03, 2025
Cash flows from operating activities:    
Net loss $ (13,266) $ (14,330)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, amortization and accretion 4,898 5,387
Noncash lease expense 14,980 14,639
Deferred taxes (1,194) (1,473)
Stock-based compensation expense 2,024 1,828
Impairment of long-lived assets 511 462
Other 126 (765)
Changes in operating assets and liabilities:    
Receivables 777 (758)
Inventories (6,534) (119)
Prepaid expenses and other assets (729) 299
Trade accounts payable 7,145 (1,357)
Accrued payroll and payroll taxes (10,537) (5,863)
Income taxes payable (4,926) (259)
Operating lease liabilities (15,947) (16,588)
Other liabilities (5,423) (3,187)
Net cash used in operating activities (28,095) (22,084)
Cash flows from investing activities:    
Additions to fixed assets (1,707) (2,219)
Purchases of marketable securities and other investments (27,088) (7,055)
Sales and maturities of marketable securities and other investments 2,544 5,086
Net cash used in investing activities (26,251) (4,188)
Cash flows from financing activities:    
Proceeds from the issuance and exercise of stock-based awards, net of tax 34 186
Repurchase of common stock (5,994) (25,215)
Net cash used in financing activities (5,960) (25,029)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (645) 1,608
Net decrease in cash, cash equivalents, and restricted cash (60,951) (49,693)
Cash, cash equivalents, and restricted cash, beginning of period 134,113 121,517
Cash, cash equivalents, and restricted cash, end of period 73,162 71,824
Supplemental disclosure on cash flow information:    
Cash paid during the period for income taxes 4,912 412
Accrual for purchases of fixed assets 1,033 $ 982
Accrual for repurchase of common stock $ 237